Abstract
Enzyme-linked immunosorbent assay (ELISA) is a quantitative analytical method used to measure the concentration of molecules in biological fluids through antigen-antibody reactions. Here we describe the measurement of anti-C1-inhibitor autoantibodies by an indirect ELISA. In this method patients’ sera are incubated in a microplate coated with plasma derived C1-inhibitor.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Harpel PC, Cooper NR (1975) Studies on human plasma C1-inactivator–enzyme interaction I. mechanisms of interaction with C1s, plasmin and trypsin. J Clin Invest 55:593–604
Arlaud G, Reboul A, Sim R, Colomb M (1979) Interaction of C1 inhibitor with the C1r and C1s subcomponents in human C1. Biochim Biophys Acta 576:151–162
Dobó J, Harmat V, Beinrohr L, Sebestyén E, Závodszky P et al (2009) MASP-1, a promiscuous complement protease: structure of its catalytic region reveals the basis of its broad specificity. J Immunol 183:1207–1214
Kerr FK, Thomas AR, Wijeyewickrema LC, Whisstock JC, Boyd SE et al (2008) Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor. Mol Immunol 45:670–677
Schreiber AD, Kaplan AP, Austen KF (1973) Inhibition of C1-inhibitor of Hageman factor fragment activation of coagulation, fibrinolysis, and kinin generation. J Clin Invest 52:1402–1409
Gigli I, Mason JW, Colman RW, Austen KF (1970) Interaction of plasma kallikrein with the C1 inhibitor. J Immunol 104:574–581
Wuillemin WA, Eldering E, Citarella F, de Ruig CP, ten Cate H, Hack CE (1996) Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa. J Biol Chem 271:12913–12918
Van Nostrand WE, McKay LD, Baker JB, Cunningham DD (1988) Functional and structural similarities between protease nexin I and C1 inhibitor. J Biol Chem 263:3979–3983
Booth NA, Walker E, Maughan R, Bennett B (1987) Plasminogen activator in normal subjects after exercise and venous occlusion: t-PA circulates as complexes with C1-inhibitor and PAI-1. Blood 69:1600–1604
Caldwell JR, Ruddy S, Schur PH et al (1972) Acquired C1 inhibitor deficiency in lymphosarcoma. Clin Immunol Immunopathol 1:39–52
Zingale LC, Castelli R, Zanichelli A, Cicardi M (2006) Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunol Allergy Clin N Am 26:669–690
Jackson J, Sim RB, Whelan A et al (1986) An IgG autoantibody which inactivates C1-inhibitor. Nature 323:722–724
Engvall E, Perlmann P (1971) Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 8:871–874
Van Weemen BK, Schuurs AH (1971) Immunoassay using antigen-enzyme conjugates. FEBS Lett 15:232–236
Aydin S (2015) Peptides 72:4–15
Lindström P, Wager O (1978) IgG autoantibody to human serum albumin studied by the ELISA-technique. Scand J Immunol 7:419–425
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Suffritti, C., Caccia, S., Berra, S., Parolin, D., Cicardi, M. (2021). Anti-C1-Inhibitor Autoantibody Detection by ELISA. In: Roumenina, L.T. (eds) The Complement System. Methods in Molecular Biology, vol 2227. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1016-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1016-9_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1015-2
Online ISBN: 978-1-0716-1016-9
eBook Packages: Springer Protocols